Aurora-A Phosphorylates, Activates, and Relocalizes the Small GTPase RalA

REFERENCES

• Anand, S., S. Penrhyn-Lowe, and A. R. Venkitaraman. 2003. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 3:51–62.
   PubMed Web of Science ®Google Scholar
• Awasthi, S., J. Cheng, S. S. Singhal, M. K. Saini, U. Pandya, S. Pikula, J. Bandorowicz-Pikula, S. V. Singh, P. Zimniak, and Y. C. Awasthi. 2000. Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin. Biochemistry 39:9327–9334.
   PubMed Web of Science ®Google Scholar
• Awasthi, S., S. S. Singhal, S. Yadav, J. Singhal, K. Drake, A. Nadkar, E. Zajac, D. Wickramarachchi, N. Rowe, A. Yacoub, P. Boor, S. Dwivedi, P. Dent, W. E. Jarman, B. John, and Y. C. Awasthi. 2005. RLIP76 is a major determinant of radiation sensitivity. Cancer Res. 65:6022–6028.
   PubMed Web of Science ®Google Scholar
• Bagrodia, S., S. J. Taylor, C. L. Creasy, J. Chernoff, and R. A. Cerione. 1995. Identification of a mouse p21Cdc42/Rac activated kinase. J. Biol. Chem. 270:22731–22737.
   PubMedGoogle Scholar
• Bischoff, J. R., L. Anderson, Y. Zhu, K. Mossie, L. Ng, B. Souza, B. Schryver, P. Flanagan, F. Clairvoyant, C. Ginther, C. S. Chan, M. Novotny, D. J. Slamon, and G. D. Plowman. 1998. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17:3052–3065.
   PubMed Web of Science ®Google Scholar
• Bivona, T. G., S. E. Quatela, B. O. Bodemann, I. M. Ahearn, M. J. Soskis, A. Mor, J. Miura, H. H. Wiener, L. Wright, S. G. Saba, D. Yim, A. Fein, I. Perez de Castro, C. Li, C. B. Thompson, A. D. Cox, and M. R. Philips. 2006. PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol. Cell 21:481–943.
   PubMed Web of Science ®Google Scholar
• Bos, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 49:4682–4689.
   PubMed Web of Science ®Google Scholar
• Bozidis, P., C. D. Williamson, and A. M. Colberg-Poley. 2007. Isolation of endoplasmic reticulum, mitochondria, and mitochondria-associated membrane fractions from transfected cells and from human cytomegalovirus-infected primary fibroblasts. Curr. Protoc. Cell Biol. 37:3.27.1–3. 27.23.
   Google Scholar
• Burum-Auensen, E., P. M. De Angelis, A. R. Schjolberg, K. L. Kravik, M. Aure, and O. P. Clausen. 2007. Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry. J. Histochem. Cytochem. 55:477–486.
   PubMedGoogle Scholar
• Cantor, S. B., T. Urano, and L. A. Feig. 1995. Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol. Cell. Biol. 15:4578–4584.
   PubMed Web of Science ®Google Scholar
• Cascone, I., R. Selimoglu, C. Ozdemir, E. Del Nery, C. Yeaman, M. White, and J. Camonis. 2008. Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs. EMBO J. 27:2375–2387.
   PubMed Web of Science ®Google Scholar
• Cawthon, R. M., P. O'Connell, A. M. Buchberg, D. Viskochil, R. B. Weiss, M. Culver, J. Stevens, N. A. Jenkins, N. G. Copeland, and R. White. 1990. Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts. Genomics 7:555–565.
   PubMed Web of Science ®Google Scholar
• Chen, X. W., M. Inoue, S. C. Hsu, and A. R. Saltiel. 2006. RalA-exocyst-dependent recycling endosome trafficking is required for the completion of cytokinesis. J. Biol. Chem. 281:38609–38616.
   PubMedGoogle Scholar
• Chien, Y., S. Kim, R. Bumeister, Y. M. Loo, S. W. Kwon, C. L. Johnson, M. G. Balakireva, Y. Romeo, L. Kopelovich, M. Gale, Jr., C. Yeaman, J. H. Camonis, Y. Zhao, and M. A. White. 2006. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 127:157–170.
   PubMed Web of Science ®Google Scholar
• Chien, Y., and M. A. White. 2003. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep. 4:800–806.
   PubMed Web of Science ®Google Scholar
• Choudhury, A., M. Dominguez, V. Puri, D. K. Sharma, K. Narita, C. L. Wheatley, D. L. Marks, and R. E. Pagano. 2002. Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. J. Clin. Invest. 109:1541–1550.
   PubMed Web of Science ®Google Scholar
• Cifone, M. A., and I. J. Fidler. 1980. Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma. Proc. Natl. Acad. Sci. U. S. A. 77:1039–1043.
   PubMed Web of Science ®Google Scholar
• Cowley, D. O., J. A. Rivera-Perez, M. Schliekelman, Y. J. He, T. G. Oliver, L. Lu, R. O'Quinn, E. D. Salmon, T. Magnuson, and T. Van Dyke. 2009. Aurora-A kinase is essential for bipolar spindle formation and early development. Mol. Cell. Biol. 29:1059–1071.
   PubMed Web of Science ®Google Scholar
• Downward, J. 2003. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3:11–22.
   PubMed Web of Science ®Google Scholar
• Feig, L. A. 2003. Ral-GTPases: approaching their 15 minutes of fame. Trends Cell Biol. 13:419–425.
   PubMed Web of Science ®Google Scholar
• Fukushige, S., F. M. Waldman, M. Kimura, T. Abe, T. Furukawa, M. Sunamura, M. Kobari, and A. Horii. 1997. Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 19:161–169.
   PubMedGoogle Scholar
• Giet, R., C. Petretti, and C. Prigent. 2005. Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol. 15:241–250.
   PubMed Web of Science ®Google Scholar
• Gigoux, V., S. L'Hoste, F. Raynaud, J. Camonis, and C. Garbay. 2002. Identification of Aurora kinases as RasGAP Src homology 3 domain-binding proteins. J. Biol. Chem. 277:23742–23746.
   PubMedGoogle Scholar
• Hahn, W. C., C. M. Counter, A. S. Lundberg, R. L. Beijersbergen, M. W. Brooks, and R. A. Weinberg. 1999. Creation of human tumour cells with defined genetic elements. Nature 400:464–468.
   PubMed Web of Science ®Google Scholar
• Hamad, N. M., J. H. Elconin, A. E. Karnoub, W. Bai, J. N. Rich, R. T. Abraham, C. J. Der, and C. M. Counter. 2002. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 16:2045–2057.
   PubMed Web of Science ®Google Scholar
• Hata, T., T. Furukawa, M. Sunamura, S. Egawa, F. Motoi, N. Ohmura, T. Marumoto, H. Saya, and A. Horii. 2005. RNA interference targeting aurora kinase A suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res. 65:2899–2905.
   PubMed Web of Science ®Google Scholar
• Hezel, A. F., A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, and R. A. Depinho. 2006. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 20:1218–1249.
   PubMed Web of Science ®Google Scholar
• Jones, S., X. Zhang, D. W. Parsons, J. C. Lin, R. J. Leary, P. Angenendt, P. Mankoo, H. Carter, H. Kamiyama, A. Jimeno, S. M. Hong, B. Fu, M. T. Lin, E. S. Calhoun, M. Kamiyama, K. Walter, T. Nikolskaya, Y. Nikolsky, J. Hartigan, D. R. Smith, M. Hidalgo, S. D. Leach, A. P. Klein, E. M. Jaffee, M. Goggins, A. Maitra, C. Iacobuzio-Donahue, J. R. Eshleman, S. E. Kern, R. H. Hruban, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. E. Velculescu, and K. W. Kinzler. 2008. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801–1806.
   PubMed Web of Science ®Google Scholar
• Jullien-Flores, V., O. Dorseuil, F. Romero, F. Letourneur, S. Saragosti, R. Berger, A. Tavitian, G. Gacon, and J. H. Camonis. 1995. Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J. Biol. Chem. 270:22473–22477.
   PubMed Web of Science ®Google Scholar
• Jullien-Flores, V., Y. Mahe, G. Mirey, C. Leprince, B. Meunier-Bisceuil, A. Sorkin, and J. H. Camonis. 2000. RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis. J. Cell Sci. 113:2837–2844.
   PubMed Web of Science ®Google Scholar
• Katayama, H., W. R. Brinkley, and S. Sen. 2003. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 22:451–464.
   PubMedGoogle Scholar
• Keen, N., and S. Taylor. 2004. Aurora-kinase inhibitors as anticancer agents. Nat. Rev. Cancer 4:927–936.
   PubMed Web of Science ®Google Scholar
• Kendall, S. D., S. J. Adam, and C. M. Counter. 2006. Genetically engineered human cancer models utilizing mammalian transgene expression. Cell Cycle 5:1074–1079.
   PubMed Web of Science ®Google Scholar
• Khosravi-Far, R., M. A. White, J. K. Westwick, P. A. Solski, M. Chrzanowska-Wodnicka, L. Van Aelst, M. H. Wigler, and C. J. Der. 1996. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell. Biol. 16:3923–3933.
   PubMed Web of Science ®Google Scholar
• Li, D., J. Zhu, P. F. Firozi, J. L. Abbruzzese, D. B. Evans, K. Cleary, H. Friess, and S. Sen. 2003. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin. Cancer Res. 9:991–997.
   PubMed Web of Science ®Google Scholar
• Lim, K. H., A. T. Baines, J. J. Fiordalisi, M. Shipitsin, L. A. Feig, A. D. Cox, C. J. Der, and C. M. Counter. 2005. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 7:533–745.
   PubMed Web of Science ®Google Scholar
• Lim, K. H., and C. M. Counter. 2005. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance. Cancer Cell 8:381–392.
   PubMed Web of Science ®Google Scholar
• Lim, K. H., K. O'Hayer, S. J. Adam, S. D. Kendall, P. M. Campbell, C. J. Der, and C. M. Counter. 2006. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr. Biol. 16:2385–2394.
   PubMed Web of Science ®Google Scholar
• Malumbres, M., and M. Barbacid. 2007. Cell cycle kinases in cancer. Curr. Opin. Genet. Dev. 17:60–65.
   PubMed Web of Science ®Google Scholar
• Malumbres, M., and M. Barbacid. 2003. RAS oncogenes: the first 30 years. Nat. Rev. Cancer 3:459–465.
   PubMed Web of Science ®Google Scholar
• Marumoto, T., S. Honda, T. Hara, M. Nitta, T. Hirota, E. Kohmura, and H. Saya. 2003. Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells. J. Biol. Chem. 278:51786–51795.
   PubMed Web of Science ®Google Scholar
• Marumoto, T., D. Zhang, and H. Saya. 2005. Aurora-A—a guardian of poles. Nat. Rev. Cancer 5:42–50.
   PubMed Web of Science ®Google Scholar
• Meraldi, P., R. Honda, and E. A. Nigg. 2002. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J. 21:483–492.
   PubMed Web of Science ®Google Scholar
• Mitin, N., L. Betts, M. E. Yohe, C. J. Der, J. Sondek, and K. L. Rossman. 2007. Release of autoinhibition of ASEF by APC leads to CDC42 activation and tumor suppression. Nat. Struct. Mol. Biol. 14:814–823.
   PubMed Web of Science ®Google Scholar
• Moskalenko, S., D. O. Henry, C. Rosse, G. Mirey, J. H. Camonis, and M. A. White. 2002. The exocyst is a Ral effector complex. Nat. Cell Biol. 4:66–72.
   PubMed Web of Science ®Google Scholar
• Norman, J., M. Franz, R. Schiro, S. Nicosia, J. Docs, P. J. Fabri, and W. R. Gower, Jr. 1994. Functional glucocorticoid receptor modulates pancreatic carcinoma growth through an autocrine loop. J. Surg. Res. 57:33–38.
   PubMedGoogle Scholar
• O'Hayer, K. M., and C. M. Counter. 2006. A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro. Methods Enzymol. 407:637–647.
   PubMed Web of Science ®Google Scholar
• Okada, T., T. Sawada, T. Osawa, M. Adachi, and K. Kubota. 2008. MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases. World J. Gastroenterol. 14:1378–1382.
   PubMedGoogle Scholar
• Pamonsinlapatham, P., R. Hadj-Slimane, F. Raynaud, M. Bickle, C. Corneloup, A. Barthelaix, Y. Lepelletier, P. Mercier, M. Schapira, J. Samson, A. L. Mathieu, N. Hugo, O. Moncorge, I. Mikaelian, S. Dufour, C. Garbay, and P. Colas. 2008. A RasGAP SH3 peptide aptamer inhibits RasGAP-Aurora interaction and induces caspase-independent tumor cell death. PLoS ONE 3:e2902.
   PubMedGoogle Scholar
• Park, S. H., and R. A. Weinberg. 1995. A putative effector of Ral has homology to Rho/Rac GTPase activating proteins. Oncogene 11:2349–2355.
   PubMed Web of Science ®Google Scholar
• Qiu, R. G., A. Abo, F. McCormick, and M. Symons. 1997. Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation. Mol. Cell. Biol. 17:3449–3458.
   PubMedGoogle Scholar
• Quaroni, A., and E. C. Paul. 1999. Cytocentrin is a Ral-binding protein involved in the assembly and function of the mitotic apparatus. J. Cell Sci. 112:707–718.
   PubMed Web of Science ®Google Scholar
• Repasky, G. A., E. J. Chenette, and C. J. Der. 2004. Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? Trends Cell Biol. 14:639–647.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Viciana, P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457–467.
   PubMed Web of Science ®Google Scholar
• Rosse, C., S. L'Hoste, N. Offner, A. Picard, and J. Camonis. 2003. RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J. Biol. Chem. 278:30597–30604.
   PubMed Web of Science ®Google Scholar
• Sablina, A. A., W. Chen, J. D. Arroyo, L. Corral, M. Hector, S. E. Bulmer, J. A. DeCaprio, and W. C. Hahn. 2007. The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell 129:969–982.
   PubMed Web of Science ®Google Scholar
• Shipitsin, M., and L. A. Feig. 2004. RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells. Mol. Cell. Biol. 24:5746–5756.
   PubMed Web of Science ®Google Scholar
• Smith, S. C., G. Oxford, A. S. Baras, C. Owens, D. Havaleshko, D. L. Brautigan, M. K. Safo, and D. Theodorescu. 2007. Expression of ral GTPases, their effectors, and activators in human bladder cancer. Clin. Cancer Res. 13:3803–3813.
   PubMed Web of Science ®Google Scholar
• Tatsuka, M., S. Sato, S. Kitajima, S. Suto, H. Kawai, M. Miyauchi, I. Ogawa, M. Maeda, T. Ota, and T. Takata. 2005. Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis. Oncogene 24:1122–1127.
   PubMed Web of Science ®Google Scholar
• Wang, X., Y. X. Zhou, W. Qiao, Y. Tominaga, M. Ouchi, T. Ouchi, and C. X. Deng. 2006. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 25:7148–7158.
   PubMed Web of Science ®Google Scholar
• Warner, S. L., R. M. Munoz, D. J. Bearss, P. Grippo, H. Han, and D. D. Von Hoff. 2008. Pdx-1-driven overexpression of aurora A kinase induces mild ductal dysplasia of pancreatic ducts near islets in transgenic mice. Pancreas 37:e39–e44.
   PubMedGoogle Scholar
• White, M. A., C. Nicolette, A. Minden, A. Polverino, L. Van Aelst, M. Karin, and M. H. Wigler. 1995. Multiple Ras functions can contribute to mammalian cell transformation. Cell 80:533–541.
   PubMed Web of Science ®Google Scholar
• Wolthuis, R. M., B. Bauer, L. J. van 't Veer, A. M. de Vries-Smits, R. H. Cool, M. Spaargaren, A. Wittinghofer, B. M. Burgering, and J. L. Bos. 1996. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. Oncogene 13:353–362.
   PubMedGoogle Scholar
• Wolthuis, R. M., N. D. de Ruiter, R. H. Cool, and J. L. Bos. 1997. Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J. 16:6748–6761.
   PubMed Web of Science ®Google Scholar
• Wolthuis, R. M., B. Franke, M. van Triest, B. Bauer, R. H. Cool, J. H. Camonis, J. W. Akkerman, and J. L. Bos. 1998. Activation of the small GTPase Ral in platelets. Mol. Cell. Biol. 18:2486–2491.
   PubMed Web of Science ®Google Scholar
• Wu, J. C., T. Y. Chen, C. T. Yu, S. J. Tsai, J. M. Hsu, M. J. Tang, C. K. Chou, W. J. Lin, C. J. Yuan, and C. Y. Huang. 2005. Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening. J. Biol. Chem. 280:9013–9022.
   PubMed Web of Science ®Google Scholar
• Yadav, S., S. S. Singhal, J. Singhal, D. Wickramarachchi, E. Knutson, T. B. Albrecht, Y. C. Awasthi, and S. Awasthi. 2004. Identification of membrane-anchoring domains of RLIP76 using deletion mutant analyses. Biochemistry 43:16243–16253.
   PubMed Web of Science ®Google Scholar
• Zhang, D., T. Hirota, T. Marumoto, M. Shimizu, N. Kunitoku, T. Sasayama, Y. Arima, L. Feng, M. Suzuki, M. Takeya, and H. Saya. 2004. Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene 23:8720–8730.
   PubMed Web of Science ®Google Scholar